Fredun [FREDUN] vs Sequent Scientific [SEQUENT] Detailed Stock Comparison

Fredun

BSE
Loading...

Sequent Scientific

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Fredun wins in 15 metrics, Sequent Scientific wins in 4 metrics, with 0 ties. Fredun appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricFredunSequent ScientificBetter
P/E Ratio (TTM)27.58166.33Fredun
Price-to-Book Ratio4.136.61Fredun
Debt-to-Equity Ratio118.2262.47Sequent Scientific
PEG Ratio0.441.40Fredun
EV/EBITDA12.8530.63Fredun
Profit Margin (TTM)4.50%1.85%Fredun
Operating Margin (TTM)12.99%7.56%Fredun
EBITDA Margin (TTM)12.99%7.56%Fredun
Return on Equity13.96%2.84%Fredun
Return on Assets (TTM)4.05%1.37%Fredun
Free Cash Flow (TTM)$-351.69M$442.73MSequent Scientific
Dividend Yield0.09%N/AN/A
1-Year Return74.09%-10.14%Fredun
Price-to-Sales Ratio (TTM)1.263.00Fredun
Enterprise Value$7.89B$50.87BSequent Scientific
EV/Revenue Ratio1.593.17Fredun
Gross Profit Margin (TTM)26.88%46.86%Sequent Scientific
Revenue per Share (TTM)$1,128$64Fredun
Earnings per Share (Diluted)$48.08$1.12Fredun
Beta (Stock Volatility)0.860.91Fredun
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Fredun vs Sequent Scientific Stock Performance Analysis

Loading Price Chart...

Fredun
Sequent Scientific
Fredun Stock Overview | Sequent Scientific Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Fredun4.88%6.70%11.52%71.28%96.73%89.92%
Sequent Scientific1.15%-8.42%9.29%-3.35%37.17%0.89%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Fredun74.09%27.27%443.09%11,052.80%11,052.80%11,052.80%
Sequent Scientific-10.14%69.59%19.72%26.36%26.36%26.36%

News Based Sentiment: Fredun vs Sequent Scientific

Fredun

News based Sentiment: POSITIVE

Fredun Pharmaceuticals experienced a remarkably positive month, achieving a new 52-week high, strong financial growth, and a commitment to shareholder returns. While the planned equity issuance introduces some complexity, the overall narrative is one of significant growth and market outperformance, making it a noteworthy event for investors.

View Fredun News Sentiment Analysis

Sequent Scientific

News based Sentiment: POSITIVE

Sequent Scientific's impressive Q1 FY2025-26 results, with a 21.9% revenue increase and a massive 1283.5% profit jump, clearly demonstrate a positive shift in the company's financial performance. This strong showing is a significant development for investors, indicating potential for future growth and returns.

View Sequent Scientific News Sentiment Analysis

Performance & Financial Health Analysis: Fredun vs Sequent Scientific

MetricFREDUNSEQUENT
Market Information
Market Cap i₹6.58B₹48.13B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i11,9711,494,055
90 Day Avg. Volume i16,431754,164
Last Close₹1,394.10₹186.29
52 Week Range₹635.00 - ₹1,395.65₹117.35 - ₹240.70
% from 52W High-0.11%-22.60%
All-Time High₹1,428.00 (Dec 05, 2022)₹336.50 (Jun 28, 2021)
% from All-Time High-2.37%-44.64%
Growth Metrics
Quarterly Revenue Growth0.52%0.13%
Quarterly Earnings Growth0.64%1.20%
Financial Health
Profit Margin (TTM) i0.05%0.02%
Operating Margin (TTM) i0.13%0.08%
Return on Equity (TTM) i0.14%0.03%
Debt to Equity (MRQ) i118.2262.47
Cash & Liquidity
Book Value per Share (MRQ)₹321.10₹28.19
Cash per Share (MRQ)₹12.65₹2.52
Operating Cash Flow (TTM) i₹-1,140,997,000₹360.47M
Levered Free Cash Flow (TTM) i₹197.39M₹218.78M
Dividends
Last 12-Month Dividend Yield i0.09%N/A
Last 12-Month Dividend i₹0.70₹0.00

Valuation & Enterprise Metrics Analysis: Fredun vs Sequent Scientific

MetricFREDUNSEQUENT
Price Ratios
P/E Ratio (TTM) i27.58166.33
Forward P/E iN/A36.89
PEG Ratio i0.441.40
Price to Sales (TTM) i1.263.00
Price to Book (MRQ) i4.136.61
Market Capitalization
Market Capitalization i₹6.58B₹48.13B
Enterprise Value i₹7.89B₹50.87B
Enterprise Value Metrics
Enterprise to Revenue i1.593.17
Enterprise to EBITDA i12.8530.63
Risk & Other Metrics
Beta i0.860.91
Book Value per Share (MRQ) i₹321.10₹28.19

Financial Statements Comparison: Fredun vs Sequent Scientific

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)FREDUNSEQUENT
Revenue/Sales i₹1.19B₹4.41B
Cost of Goods Sold i₹873.04M₹2.35B
Gross Profit i₹320.99M₹2.07B
Research & Development i₹7.55MN/A
Operating Income (EBIT) i₹155.72M₹333.50M
EBITDA i₹169.91M₹505.30M
Pre-Tax Income i₹90.40M₹255.20M
Income Tax i₹22.75M₹79.50M
Net Income (Profit) i₹67.66M₹175.70M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)FREDUNSEQUENT
Cash & Equivalents i₹6.37M₹626.60M
Total Current Assets i₹4.28B₹8.74B
Total Current Liabilities i₹3.28B₹5.05B
Long-Term Debt i₹96.13M₹3.00B
Total Shareholders Equity i₹1.41B₹7.70B
Retained Earnings i₹628.39M₹1.25B
Property, Plant & Equipment i₹95.24M₹2.84B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)FREDUNSEQUENT
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricFREDUNSEQUENT
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i11,9711,494,055
Average Daily Volume (90 Day) i16,431754,164
Shares Outstanding i4.72M249.89M
Float Shares i2.72M118.88M
% Held by Insiders i0.59%0.52%
% Held by Institutions i0.00%0.13%

Dividend Analysis & Yield Comparison: Fredun vs Sequent Scientific

MetricFREDUNSEQUENT
Last 12-Month Dividend i₹0.70₹0.00
Last 12-Month Dividend Yield i0.09%N/A
3-Year Avg Annual Dividend i₹0.70₹0.00
3-Year Avg Dividend Yield i0.08%N/A
3-Year Total Dividends i₹2.10₹0.00
Ex-Dividend DateSep 23, 2024N/A